IRulya Therapeutics IRLA Director · filings 2026 to 2026
No transactions in the filings read; Form 144 notices are listed above.
Person · CIK 2159117
James Elwood Valentine
Director at IRulya Therapeutics
Sold on Form 4$0
Noticed on Form 144$0
Bought on Form 4$0
Companies1
Holdings now
No holdings reported in the filings read so far.
Sold and noticed by quarter
No sales or Form 144 notices with a stated value.
Every transaction, by company
Each Form 3, 4 and 5 transaction in plain words, newest first.
How these figures work
Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.
All 1 Forms 3, 4, 5 and 144
| Filed | Form | Company | Links |
|---|---|---|---|
| Oct 19, 2026 | Form 3 | IRulya Therapeutics IRLA | Filing · EDGAR |
Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.